Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Use of stereotactic body radiation therapy with salvage surgery to improve outcomes for early stage non-small cell lung cancer

Senthi S

(2014), J Thorac Cardiovasc Surg, 148(4), 1760

Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register

Papa N, Lawrentschuk N, Muller D, MacInnis R, Ta A, Severi G, Millar J, Syme R, Giles G, Bolton D

(2014), Aust N Z J Public Health, 38(5), 449-54

An evaluation of dose equivalence between synchrotron microbeam radiation therapy and conventional broad beam radiation using clonogenic and cell impedance assays

Ibahim MJ, Crosbie JC, Yang Y, Zaitseva M, Stevenson AW, Rogers PA, Paiva P

(2014), PLoS One, 9(6), e100547

Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis

Ruben JD, Smith R, Lancaster CM, Haynes M, Jones P, Panettieri V

(2014), Int J Radiat Oncol Biol Phys, 90(3), 645-53

Cerebral radiation necrosis

Na A, Haghigi N, Drummond KJ

(2014), Asia Pac J Clin Oncol, 10(1), 11-21

Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

Dearnaley DP, Jovic G, Syndikus I, Khoo V, Cowan RA, Graham JD, Aird EG, Bottomley D, Huddart RA, Jose CC, Matthews JH, Millar JL, Murphy C, Russell JM, Scrase CD, Parmar MK, Sydes MR

(2014), Lancet Oncol, 15(4), 464-73

Dose variations caused by setup errors in intracranial stereotactic radiotherapy: a PRESAGE study

Teng K, Gagliardi F, Alqathami M, Ackerly T, Geso M

(2014), Med Dosim, 39(4), 292-9

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial

Pearse M, Fraser-Browne C, Davis ID, Duchesne GM, Fisher R, Frydenberg M, Haworth A, Jose C, Joseph DJ, Lim TS, Matthews J, Millar J, Sidhom M, Spry NA, Tang CI, Turner S, Williams SG, Wiltshire K, Woo HH, Kneebone A

(2014), BJU Int, 113 Suppl 2, 7-12

Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer

Warren S, Panettieri V, Panakis N, Bates N, Lester JF, Jain P, Landau DB, Nahum AE, Mayles WP, Fenwick JD

(2014), Int J Radiat Oncol Biol Phys, 88(5), 1148-53

Investigating strategies to reduce toxicity in stereotactic ablative radiotherapy for central lung tumors

Senthi S, Dahele M, Slotman BJ, Senan S

(2014), Acta Oncol, 53(3), 330-5

Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy

Panettieri V, Smith RL, Mason NJ, Millar JL

(2014), J Appl Clin Med Phys, 15(6), 5055

Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer

Ong WL, Hindson BR, Beaufort C, Pharoah P, Millar JL

(2014), Radiother Oncol, 112(1), 72-6

Desmoid Tumours: 3 cases involving the root of neck and literature review

Moore EC, Lee J, Davis S, Serpell J

(2014), J Solid Tumor, 4(4), 36-42

The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry

Stirling RG, Evans SM, McLaughlin P, Senthuren M, Millar J, Gooi J, Irving L, Mitchell P, Haydon A, Ruben J, Conron M, Leong T, Watkins N, McNeil JJ

(2014), Lung, 192(5), 749-58

In vivo characterization and numerical simulation of prostate properties for non-thermal irreversible electroporation ablation

Neal RE 2nd, Millar JL, Kavnoudias H, Royce P, Rosenfeldt F, Pham A, Smith R, Davalos RV, Thomson KR

(2014), Prostate, 74(5), 458-68

Factors associated with symptom-specific psychological and functional impact among acoustic neuroma patients

Brooker JE, Fletcher JM, Dally MJ, Briggs RJS, Cousins VC, Malham GM, Kennedy RJ, Smee RJ, Burney S

(2014), J Laryngol Otol, 128 Suppl 2, S16-26

Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry

Evans SM, Millar JL, Frydenberg M, Murphy DG, Davis ID, Spelman T, Bolton DM, Giles GG, Dean J, Costello AJ, Frauman AG, Kearns PA, Day L, Daniels C, McNeil JJ

(2014), BJU Int, 114(5), 680-90

Low uptake of upfront autologous transplantation for myeloma in a jurisdiction with universal health care coverage: a population-based patterns of care study in Australia

Wong Doo N, Coory M, White V, Harrison SJ, Prince HM, Millar JL, Dimech M, Giles GG, IMPROVE Project

(2014), Clin Lymphoma Myeloma Leuk, 14(1), 61-7

Respiratory-gated thoracic radiotherapy: much complexity for how much gain?

Ruben JD

(2013), J Med Imaging Radiat Oncol, 57(6), 701-3

Contemporary management of renal cell carcinoma (RCC) in Victoria: implications for longer term outcomes and costs

Ta AD, Bolton DM, Dimech MK, White V, Davis ID, Coory M, Millar J, Giles G

(2013), BJU Int, 112 Suppl 2, 36-43

8 9 10 11 12